Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson's disease

A PDF of the poster presented at the FENS Forum 2024 conference is available on the Science & Technology section of the Company's website at https://www.gaintherapeutics.com/science-and-technology/posters. Forward Looking Statements Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Silverstein Foundation for Parkinson's with GBA, as well "These data further confirm our conviction that GT-02287 can slow or st ...